Optimal spending functions for asymmetric group sequential designs.

Biom J

Merck Research Laboratories, UG1C-46, 351 Sumneytown Pike, Upper Gwynedd, PA 19454-2505, USA.

Published: June 2007

We present optimized group sequential designs where testing of a single parameter theta is of interest. We require specification of a loss function and of a prior distribution for theta. For the examples presented, we pre-specify Type I and II error rates and minimize the expected sample size over the prior distribution for theta. Minimizing the square of sample size rather than the sample size is found to produce designs with slightly less aggressive interim stopping rules and smaller maximum sample sizes with essentially identical expected sample size. We compare optimal designs using Hwang-Shih-DeCani and Kim-DeMets spending functions to fully optimized designs not restricted by a spending function family. In the examples selected, we also examine when there might be substantial benefit gained by adding an interim analysis. Finally, we provide specific optimal asymmetric spending function designs that should be generally useful and simply applied when a design with minimal expected sample size is desired.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bimj.200510205DOI Listing

Publication Analysis

Top Keywords

sample size
20
expected sample
12
spending functions
8
group sequential
8
sequential designs
8
prior distribution
8
distribution theta
8
spending function
8
designs
6
sample
6

Similar Publications

Adverse reactions caused by waterborne contaminants constitute a major hazard to the environment. Controlling the pollutants released into aquatic systems through water degradation has been one of the major concerns of recent research. Bismuth-based perovskites have exhibited outstanding properties in the field of photocatalysis.

View Article and Find Full Text PDF

Objective: To evaluate the effect of disease stage, frequency and clustering of visual field (VF) tests, inclusion of 1 or both eyes, and 1 (1 arm; before and after a treatment) or 2 groups (2 arms; treatment and control arm) on sample size calculation in clinical trials.

Design: Clinical cohort study.

Participants: A series of VFs were simulated based on test-retest VF data in the early, moderate, and advanced stages of glaucoma with 231, 204, and 226 eyes, respectively.

View Article and Find Full Text PDF

Objective: Our objective of this study was to analyse all oncological clinical trials using regorafenib to create a complete risk/benefit profile for the drug.

Background: Creating a novel chemotherapy is costly both in time and capital spent for drug manufacturers. To regenerate what they've spent, drug manufacturers may attempt to repurpose their medications for new indications via clinical trials.

View Article and Find Full Text PDF

Introduction: Hepatitis B and C are viral infections causing chronic liver inflammation and, when left untreated, lead to cirrhosis and a risk for hepatocellular carcinoma, the most common type of primary liver cancer with high mortality. The hepatitis B virus-hepatitis C virus (HBV-HCV) coinfection leads to a faster progression to advanced liver diseases and higher hepatocellular carcinoma (HCC) risk than monoinfection. Unlike the relative risk for HCC due to either HBV or HCV, no recent analysis of the risk for HBV-HCV coinfection exists.

View Article and Find Full Text PDF

Background: Fertility preferences refer to the number of children an individual would like to have, regardless of any obstacles that may stand in the way of fulfilling their aspirations. Despite the creation and application of numerous interventions, the overall fertility rate in West African nations, particularly Nigeria, is still high at 5.3% according to 2018 Nigeria Demographic and Health Survey data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!